Market report
Pharmaceutical tenders in Czechia — market report, February 2026
Pharmaceutical tenders in Czechia in February 2026: 8,564 tenders published (-3% month on month, -1% year on year), estimated at €20,580,465 in total, and 8,589 contracts awarded (-4% month on month, -1% year on year), worth €65,148,878 (awarded value). Buyers with the most tenders: Fakultní nemocnice Olomouc (725), Institut klinické a experimentální medicíny (725) and Fakultní nemocnice Brno (722); most contracts won: ROCHE s.r.o. (236), ViaPharma s.r.o. (169) and Janssen-Cilag s.r.o. (160). On average 4.3 bids per contract; 52% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 8,564
- Contracts awarded
- 8,589
- Contract value awarded
- €65,148,878
- Bids per contract
- 4.3
The highlighted bar is February 2026. Hover a bar for its figure; the table below has every value.
| Figure | February 2026 | January 2026 | Change | February 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 8,564 | 8,798 | -3% | 8,674 | -1% |
| Estimated value | €20,580,465 | €77,576,457 | -73% | €63,733,516 | -68% |
| Buyers | 79 | 81 | -2% | 84 | -6% |
| Contracts awarded | 8,589 | 8,929 | -4% | 8,691 | -1% |
| Contract value (awarded) | €65,148,878 | €48,447,625 | +34% | €15,047,523 | +333% |
| Winners | 395 | 374 | +6% | 379 | +4% |
| Bids per contract | 4.3 | 3.2 | — | 8.5 | — |
| Single-bid contracts | 52% | 54% | — | 44% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ROCHE s.r.o. | 236 |
| 2 | ViaPharma s.r.o. | 169 |
| 3 | Janssen-Cilag s.r.o. | 160 |
| 4 | Takeda Pharmaceuticals Czech Republic s.r.o. | 150 |
| 5 | AbbVie s.r.o. | 140 |
| 6 | Amgen s.r.o. | 139 |
| 7 | Avenier a.s. | 131 |
| 8 | BAYER s.r.o. | 101 |
| 9 | CARDION s.r.o. | 99 |
| 10 | ResMed CZ s.r.o. | 97 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Medicines and pharmaceuticals
Questions and answers
- How many pharmaceutical tenders were published in Czechia in February 2026?
- 8,564 (by 79 buyers); for comparison, January 2026: 8,798, February 2025: 8,674.
- Who won the most pharmaceutical tenders in Czechia in February 2026?
- By number of contracts: ROCHE s.r.o. (236), ViaPharma s.r.o. (169), Janssen-Cilag s.r.o. (160), Takeda Pharmaceuticals Czech Republic s.r.o. (150) and AbbVie s.r.o. (140); 395 companies won contracts in all.
- Which buyers published the most pharmaceutical tenders in February 2026?
- Fakultní nemocnice Olomouc (725), Institut klinické a experimentální medicíny (725), Fakultní nemocnice Brno (722), Krajská zdravotní, a.s. (718) and Fakultní nemocnice Bulovka (665).
- How competitive were pharmaceutical tenders in Czechia in February 2026?
- On average 4.3 bids per contract (126 contracts with a known number of bids); 52% of contracts had a single bid.
- What were the contracts worth in February 2026?
- €65,148,878 (awarded value, 8,589 contracts); median about €210,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.